Results 211 to 220 of about 4,784,374 (307)

Arginine methylation as a regulatory ratchet in cancer: From substrate selection to malignant‐state stabilization

Molecular Oncology, EarlyView.
Arginine methylation can be viewed as a persistence‐prone post‐translational modification regulated by a network of PRMTs. Competitive and compensatory interactions among PRMTs can redistribute methylation across substrate pools shaped by sequence, structural, spatial, and environmental layers, reinforcing RNA‐processing, chromatin, and signaling ...
So Hyun Kwon, Ji Min Lee
wiley   +1 more source

Cost-Effectiveness of Smoking Cessation Interventions Integrated Into Lung Cancer Screening.

JAMA Netw Open
Cao P, Smith L, Tian E, Chichester LA, Schofield E, Williams RM, Meza R, Toll BA, Ostroff J, Elkin EB, Fu SS, Land SR, Taylor KL, Jayasekera J.   +13 more
europepmc   +1 more source

Artificial Intelligence as an Assistive Tool in Breast Cancer Screening and Diagnosis in the Digital Era. [PDF]

Int J Breast Cancer
Rana MK, Singh A, Rana AS, Kaur S, Jain A, Gupta A, Kaur U.   +6 more
europepmc   +1 more source

Corrigendum: Stigma related to screening, brief intervention, and referral intervention for behavioral health risk factors in healthcare settings: A systematic review

Population Medicine
Adetola Aboyeji, Sharon Mah, Gary Teare, Kamala Adhikari   +3 more
doaj   +1 more source

Mechanisms and therapeutic opportunities of the ribotoxic stress response in cancer

Molecular Oncology, EarlyView.
Cancer cells' high translational demand creates opportunities to therapeutically target ribosome function. Ribosome stalling and collisions activate ZAKα and the ribotoxic stress response (RSR), which can trigger rapid, p53‐independent apoptosis in cancer.
Anastassiya Kim, Maryam Aslam, Elouise Torruella, Alphons Sony, Asif Rahman, Simira Smith, Columba de la Parra, Moira Sauane   +7 more
wiley   +1 more source

Women's compliance with cervical cancer screening recommendations and associated barriers to participation: A cross-sectional analysis. [PDF]

PLoS One
Spriņģe L, Ķīvīte-Urtāne A, Tihomirova Ļ, Stars I, Mikule E, Žodžika J, Bukova-Žideļūna A, Pärna K, Nygard M, Uusküla A.   +9 more
europepmc   +1 more source

Profiling neoadjuvant therapy response in rectal cancer using meta‐analysis of publicly available transcriptomic RNA‐seq datasets

Molecular Oncology, EarlyView.
This study integrates publicly available transcriptomic datasets to identify molecular signatures associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. By analyzing a combination of multiple cohorts with bioinformatics approaches, we reveal biological pathways and immune‐related features that may improve ...
Aleksandra Stanojevic, Rafael Stroggilos, Mladen Marinkovic, Ana Djuric, Suzana Stojanovic‐Rundic, Radmila Jankovic, Sergi Castellvi‐Bel, Remond J.A. Fijneman, Antonia Vlahou, Jerome Zoidakis, Milena Cavic   +10 more
wiley   +1 more source

SNAP Participation and Cancer Screening for Adults With Food Insecurity.

JAMA Netw Open
Mevawalla A, Chatzipanagiotou OP, Sarfraz A, Alizai Q, Angez M, Elemosho A, Chaudhry MQ, Zindani S, Pawlik TM.   +8 more
europepmc   +1 more source

Prostate Cancer Screening: Current Controversies and Future Directions. [PDF]

Cureus
Buali HF, Al Shaibani A, Farouqi US, Abushloa T, Bastawisy A, Aljeeran N, Albenjasim K, Rafie M.   +7 more
europepmc   +1 more source

The VHL tumor suppressor at the crossroad of protein folding, aggregation, and cancer

Molecular Oncology, EarlyView.
Mutations, environmental stress, and chaperone dysfunction can destabilize pVHL, promoting its conversion from the native folded state into amyloid‐like assemblies. This transition may contribute to protein storage, cell dormancy, survival, and drug resistance.
Lara Abad, Silvio Carlo Ermanno Tosatto, Emanuela Leonardi   +2 more
wiley   +1 more source